Safety and Tolerability of Subcutaneous IgPro20 at High Infusion Parameters in Patients with Primary Immunodeficiency: Findings from the Pump-Assisted Administration Cohorts of the HILO Study

PURPOSE: To evaluate the safety and tolerability of subcutaneous IgPro20 (Hizentra(®), CSL Behring, King of Prussia, PA, USA) administered at high infusion parameters (> 25 mL and > 25 mL/h per injection site) in patients with primary immunodeficiency. METHODS: The Hizentra(®) Label Optimizati...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Clin Immunol
Huvudupphovsmän: Anderson, John T., Bonagura, Vincent R., Cowan, Juthaporn, Hsu, Connie, Mustafa, S. Shahzad, Patel, Niraj C., Routes, John M., Sriaroon, Panida, Vinh, Donald C., Hofmann, Jutta H., Praus, Michaela, Rojavin, Mikhail A.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Springer US 2021
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7858210/
https://ncbi.nlm.nih.gov/pubmed/33409867
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10875-020-00912-5
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk